CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Repligen Announces $1 Billion Convertible Senior Notes Offering

By Public Technologies
  • Repligen will issue $1 billion of 0.25% Convertible Senior Notes due 2031 through privately negotiated exchange and subscription transactions.
  • Approximately $541.4 million of new notes will replace $456.8 million of outstanding 1.00% Convertible Senior Notes due 2028.
  • Cash subscriptions will raise approximately $458.6 million; about $120 million of net proceeds will fund share repurchases at $188.64 per share.
  • The initial conversion price is approximately $226.37 per share, a 20% premium to the October 29, 2026, closing price.
  • Closing is expected around November 6, 2026; approximately $143.2 million of the 2028 notes will remain outstanding with unchanged terms.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Repligen Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610300600PRIMZONEFULLFEED9856841) on October 30, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk